KNC LABORATORIES CO., LTD.

Other languages KNC Laboratories Co., Ltd.

Equities

6568

JP3290400005

Market Closed - Japan Exchange Other stock markets 07:00:00 31/05/2024 BST			5-day change	1st Jan Change
1,283 ^JPY	+2.39%		-0.54%	-11.70%

03-14	KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.	CI
2022	Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.	03-13
Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022.	16/05/22
KNC Laboratories Co., Ltd.'s Equity Buyback announced on May 13, 2022, has closed with 100,000 shares, representing 1.29% for ¥111.5 million.	15/05/22
KNC Laboratories Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 1.29% for ¥111.5 million.	13/05/22
KNC Laboratories Co., Ltd. authorizes a Buyback Plan.	12/05/22
Certain Common Shares of KNC Laboratories Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-SEP-2018.	09/09/18
KNC Laboratories Co., Ltd. has completed an IPO in the amount of ¥5.30712 billion.	14/03/18
KNC Laboratories Co., Ltd. has filed an IPO.	09/02/18
Kobe University, Knc Laboratories Co.,Ltd., and Dainippon Sumitomo Pharma Co., Ltd. Signs License Agreement and Joint Research Agreement	26/12/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer